NASDAQ:AGTC

Applied Genetic Technologies Stock Forecast, Price & News

$4.03
-0.03 (-0.74 %)
(As of 04/13/2021 11:15 AM ET)
Add
Compare
Today's Range
$3.98
Now: $4.03
$4.12
50-Day Range
$4.41
MA: $5.26
$7.03
52-Week Range
$3.56
Now: $4.03
$9.67
Volume16,708 shs
Average Volume2.99 million shs
Market Capitalization$172.29 million
P/E RatioN/A
Dividend YieldN/A
Beta2.33
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which has completed Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate for the patients with advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and three preclinical programs in targeting central nervous system disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, and adrenoleukodystrophy. It has collaboration agreements with Synpromics Limited; University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.
Applied Genetic Technologies logo

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AGTC
CUSIPN/A
Phone386-462-2204
Employees83
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.45 million
Book Value$2.76 per share

Profitability

Net Income$-45,890,000.00

Miscellaneous

Market Cap$172.29 million
Next Earnings Date5/12/2021 (Estimated)
OptionableOptionable

Headlines

AGTC to Present at Upcoming Investor Conferences
March 2, 2021 |  finance.yahoo.com
Applied Genetic Technologies Corp. to Host Earnings Call
February 11, 2021 |  finance.yahoo.com
Applied Genetic Technologies
January 22, 2021 |  fool.com
Applied Genetic Technologies Corp/DE
January 22, 2021 |  bloomberg.com
Is AGTC A Good Stock To Buy Now?
December 11, 2020 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

1.47 out of 5 stars

Medical Sector

560th out of 2,016 stocks

Biological Products, Except Diagnostic Industry

80th out of 177 stocks

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
$4.03
-0.03 (-0.74 %)
(As of 04/13/2021 11:15 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AGTC News and Ratings via Email

Sign-up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Applied Genetic Technologies (NASDAQ:AGTC) Frequently Asked Questions

Is Applied Genetic Technologies a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Applied Genetic Technologies in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Applied Genetic Technologies stock.
View analyst ratings for Applied Genetic Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than Applied Genetic Technologies?

Wall Street analysts have given Applied Genetic Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Applied Genetic Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Applied Genetic Technologies?

Applied Genetic Technologies saw a increase in short interest in February. As of February 26th, there was short interest totaling 2,360,000 shares, an increase of 44.8% from the February 11th total of 1,630,000 shares. Based on an average daily trading volume, of 2,690,000 shares, the days-to-cover ratio is presently 0.9 days.
View Applied Genetic Technologies' Short Interest
.

When is Applied Genetic Technologies' next earnings date?

Applied Genetic Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, May 12th 2021.
View our earnings forecast for Applied Genetic Technologies
.

How were Applied Genetic Technologies' earnings last quarter?

Applied Genetic Technologies Co. (NASDAQ:AGTC) released its quarterly earnings results on Wednesday, February, 10th. The biotechnology company reported ($0.60) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.59) by $0.01.
View Applied Genetic Technologies' earnings history
.

How has Applied Genetic Technologies' stock price been impacted by COVID-19?

Applied Genetic Technologies' stock was trading at $3.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AGTC shares have increased by 4.9% and is now trading at $4.03.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for AGTC?

6 brokers have issued 1 year price targets for Applied Genetic Technologies' shares. Their forecasts range from $7.50 to $35.00. On average, they anticipate Applied Genetic Technologies' share price to reach $17.58 in the next twelve months. This suggests a possible upside of 336.3% from the stock's current price.
View analysts' price targets for Applied Genetic Technologies
or view top-rated stocks among Wall Street analysts.

Who are Applied Genetic Technologies' key executives?

Applied Genetic Technologies' management team includes the following people:
  • Ms. Susan B. Washer, Pres, CEO & Director (Age 60, Pay $795.26k)
  • Dr. Mark S. Shearman, Chief Scientific Officer (Age 61, Pay $613.92k)
  • Mr. Stephen W. Potter, VP & Chief Bus. Officer (Age 65, Pay $486.77k)
  • Dr. Matthew Feinsod, Exec. VP of Global Strategy & Devel. (Age 50, Pay $549.67k)
  • Dr. Nicholas Muzyczka, Co-Founder
  • Dr. Barry J. Byrne, Co-Founder
  • Dr. William W. Hauswirth, Co-Founder & Member of Ophthalmology Scientific Advisory Board
  • Dr. Richard Jude Samulski, Co-Founder
  • Dr. Terence R. Flotte, Co-Founder
  • Mr. William A. Sullivan, Chief Financial Officer (Age 50)

Who are some of Applied Genetic Technologies' key competitors?

What other stocks do shareholders of Applied Genetic Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Genetic Technologies investors own include Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Micron Technology (MU), VBI Vaccines (VBIV), Amarin (AMRN), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Anavex Life Sciences (AVXL), Galmed Pharmaceuticals (GLMD) and Genocea Biosciences (GNCA).

What is Applied Genetic Technologies' stock symbol?

Applied Genetic Technologies trades on the NASDAQ under the ticker symbol "AGTC."

How do I buy shares of Applied Genetic Technologies?

Shares of AGTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied Genetic Technologies' stock price today?

One share of AGTC stock can currently be purchased for approximately $4.03.

How much money does Applied Genetic Technologies make?

Applied Genetic Technologies has a market capitalization of $172.29 million and generates $2.45 million in revenue each year. The biotechnology company earns $-45,890,000.00 in net income (profit) each year or ($2.17) on an earnings per share basis.

How many employees does Applied Genetic Technologies have?

Applied Genetic Technologies employs 83 workers across the globe.

What is Applied Genetic Technologies' official website?

The official website for Applied Genetic Technologies is www.agtc.com.

Where are Applied Genetic Technologies' headquarters?

Applied Genetic Technologies is headquartered at 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615.

How can I contact Applied Genetic Technologies?

Applied Genetic Technologies' mailing address is 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615. The biotechnology company can be reached via phone at 386-462-2204 or via email at [email protected]


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.